Name | Number of supported studies | Average coverage | |
---|---|---|---|
pericyte | 5 studies | 29% ± 12% | |
smooth muscle cell | 3 studies | 30% ± 11% |
Insufficient scRNA-seq data for expression of AVPR1A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 97% | 2669.35 | 444 / 459 | 89% | 3.86 | 999 / 1118 |
thymus | 99% | 1879.52 | 649 / 653 | 71% | 4.43 | 431 / 605 |
adrenal gland | 100% | 8072.23 | 257 / 258 | 50% | 6.16 | 114 / 230 |
uterus | 97% | 2131.11 | 165 / 170 | 46% | 2.29 | 211 / 459 |
liver | 91% | 3029.38 | 206 / 226 | 51% | 9.55 | 207 / 406 |
prostate | 66% | 457.43 | 161 / 245 | 71% | 2.09 | 357 / 502 |
kidney | 69% | 614.85 | 61 / 89 | 64% | 11.70 | 581 / 901 |
bladder | 81% | 684.57 | 17 / 21 | 46% | 1.78 | 234 / 504 |
esophagus | 46% | 342.75 | 662 / 1445 | 72% | 2.05 | 131 / 183 |
adipose | 100% | 4081.00 | 1204 / 1204 | 0% | 0 | 0 / 0 |
skin | 43% | 310.32 | 771 / 1809 | 53% | 2.53 | 252 / 472 |
stomach | 42% | 340.37 | 152 / 359 | 53% | 1.70 | 153 / 286 |
pancreas | 5% | 25.34 | 18 / 328 | 81% | 5.30 | 145 / 178 |
intestine | 48% | 360.96 | 460 / 966 | 35% | 0.97 | 182 / 527 |
ovary | 21% | 285.88 | 37 / 180 | 60% | 1.63 | 259 / 430 |
blood vessel | 74% | 4438.92 | 993 / 1335 | 0% | 0 | 0 / 0 |
lung | 10% | 55.42 | 55 / 578 | 46% | 1.73 | 527 / 1155 |
tonsil | 0% | 0 | 0 / 0 | 47% | 1.10 | 21 / 45 |
lymph node | 0% | 0 | 0 / 0 | 28% | 0.50 | 8 / 29 |
muscle | 27% | 168.09 | 220 / 803 | 0% | 0 | 0 / 0 |
heart | 24% | 142.73 | 206 / 861 | 0% | 0 | 0 / 0 |
brain | 0% | 2.01 | 10 / 2642 | 23% | 0.55 | 164 / 705 |
eye | 0% | 0 | 0 / 0 | 5% | 0.11 | 4 / 80 |
spleen | 2% | 22.29 | 6 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 2.41 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007625 | Biological process | grooming behavior |
GO_0006091 | Biological process | generation of precursor metabolites and energy |
GO_0014049 | Biological process | positive regulation of glutamate secretion |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0032849 | Biological process | positive regulation of cellular pH reduction |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0150104 | Biological process | transport across blood-brain barrier |
GO_0014902 | Biological process | myotube differentiation |
GO_0045907 | Biological process | positive regulation of vasoconstriction |
GO_0032870 | Biological process | cellular response to hormone stimulus |
GO_0031394 | Biological process | positive regulation of prostaglandin biosynthetic process |
GO_0042713 | Biological process | sperm ejaculation |
GO_0051970 | Biological process | negative regulation of transmission of nerve impulse |
GO_0001992 | Biological process | regulation of systemic arterial blood pressure by vasopressin |
GO_0002125 | Biological process | maternal aggressive behavior |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0042711 | Biological process | maternal behavior |
GO_0003084 | Biological process | positive regulation of systemic arterial blood pressure |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0007621 | Biological process | negative regulation of female receptivity |
GO_0008015 | Biological process | blood circulation |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0035176 | Biological process | social behavior |
GO_0042631 | Biological process | cellular response to water deprivation |
GO_0051412 | Biological process | response to corticosterone |
GO_0010460 | Biological process | positive regulation of heart rate |
GO_0021537 | Biological process | telencephalon development |
GO_0005886 | Cellular component | plasma membrane |
GO_0030139 | Cellular component | endocytic vesicle |
GO_0005768 | Cellular component | endosome |
GO_0005080 | Molecular function | protein kinase C binding |
GO_0042277 | Molecular function | peptide binding |
GO_0017046 | Molecular function | peptide hormone binding |
GO_0031894 | Molecular function | V1A vasopressin receptor binding |
GO_0005000 | Molecular function | vasopressin receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | AVPR1A |
Protein name | Vasopressin V1a receptor Vasopressin V1a receptor (V1aR) (AVPR V1a) (Antidiuretic hormone receptor 1a) (Vascular/hepatic-type arginine vasopressin receptor) |
Synonyms | AVPR1 |
Description | FUNCTION: Receptor for arginine vasopressin. The activity of this receptor is mediated by G proteins which activate a phosphatidyl-inositol-calcium second messenger system. Has been involved in social behaviors, including affiliation and attachment. . FUNCTION: Receptor for arginine vasopressin. The activity of this receptor is mediated by G proteins which activate a phosphatidyl-inositol-calcium second messenger system. . FUNCTION: Receptor for arginine vasopressin. The activity of this receptor is mediated by G proteins which activate a phosphatidyl-inositol-calcium second messenger system. . FUNCTION: Receptor for arginine vasopressin. The activity of this receptor is mediated by G proteins which activate a phosphatidyl-inositol-calcium second messenger system. . |
Accessions | ENST00000550940.1 P37288 F8VW98 X5D2B0 X5D789 ENST00000299178.4 |